Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

WuXi in $3bn deal to manufacture 'first of its kind' vaccine

WuXi Vaccines will build a dedicated manufacturing facility for an unnamed global vaccine leader, under a 20-year contract.

US Senate authorises increased spending on pandemic flu products

The Senate has passed a bill authorising spending on the development of products to protect the US against pandemic influenza and other biological threats to public health.

Cryoport expands into biostorage with Cryogene acquisition

Cryoport acquires Cryogene to gain access to the latter company’s 21,000-square-foot biostorage facility in Houston.

Avantor wraps up $2.9bn IPO, looks to biopharma for growth

Avantor has raised $2.9bn through an initial public offering ahead of a planned expansion of its biopharma product line.

Genentech and Parvus develop autoimmune therapies in collaboration

Genentech will collaborate with biopharma company Parvus to manufacture and commercialize Navacim therapeutics for the treatment of autoimmune disease.